XELJANZ

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 01c23f3bf72df8f9
Drug Approval Canada Name: XELJANZ
Product Name: XELJANZ
Status: Marketed
Status Date: 2019-01-30
Original Market Date: 2019-01-30
Din: 02480786
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:24.12.92
Atc Original: L04AF01 TOFACITINIB
Atc Name: l 04 af 01
Aig Number: 0155550003
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

TOFACITINIB (TOFACITINIB CITRATE)

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

01c23f3bf72df8f9

Type

Standard